Taysha Gene Therapies, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Taysha Gene Therapies, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q3 2024.
  • Taysha Gene Therapies, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 205M shares, a 9.62% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 205M +18M +9.62% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 201M +137M +213% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 187M +124M +195% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 187M +124M +196% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 187M +146M +354% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 64.4M +23.4M +57.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 63.5M +25M +65% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 63.2M +24.7M +64.3% Dec 31, 2022 10-K 2024-03-19
Q3 2022 41.2M +2.7M +7.02% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41M +2.63M +6.85% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 38.5M +713K +1.89% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 38.5M +713K +1.89% Dec 31, 2021 10-K 2023-03-28
Q3 2021 38.5M +713K +1.89% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 38.4M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 37.8M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 37.8M +26.9M +247% Dec 31, 2020 10-K 2022-03-31
Q3 2020 37.8M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 10.9M Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.